Der Anaesthesist
-
Retracted Publication
[Comparison of sublingual and intravenous administration of lorazepam in psychiatric emergencies in emergency medical services].
Agitation is a frequent reason for emergency physician calls in psychiatric emergencies in the German preclinical emergency medical system. Benzodiazepines have proven to be effective in treating acute agitation. Although lorazepam has beneficial clinical and pharmacological properties it is hardly used by emergency physicians. The sublingual administration of lorazepam has many advantages compared to intravenous administration. ⋯ Sublingual administration of lorazepam is effective for treating acute agitation in emergency medical services.
-
Randomized Controlled Trial Comparative Study Retracted Publication
Comparison between dexmedetomidine and remifentanil infusion in emergence agitation during recovery after nasal surgery : A randomized double-blind trial.
Postoperative emergency agitation (EA) is a common problem. Dexmedetomidine and remifentanil may be used to prevent this problem. Our primary aim was to compare dexmedetomidine, remifentanil, and placebo with respect to their effectiveness in preventing postoperative EA. ⋯ Anesthetic maintenance with either remifentanil or dexmedetomidine infusion until extubation provided a more smooth and hemodynamically stable emergence, without complications after nasal surgery. While remifentanil was superior to dexmedetomidine with regard to avoiding EA, dexmedetomidine was more effective than remifentanil regarding vomiting and pain.
-
Retraction Of Publication
RETRACTED ARTICLE: Different anesthesia methods for laparoscopic cholecystectomy.
-
Retraction Of Publication
[Erratum to: Propofol administration systems. Handling, hemodynamics and propofol consumption].
-
Review Retracted Publication
[Volume replacement in critically ill intensive-care patients. No classic review].
Effective fluid therapy is a mainstay of managing the critically ill. The ideal kind of volume replacement in this situation still remains a challenge. In spite of an immense number of contributions to this problem there is still no solution yet. ⋯ However, there seems to be no convincing clinical advantage on patients' outcome for either solution. The lack of acceptance of synthetic colloids such as hydroxyethyl starch (HES) solution for volume replacement is most likely due to reports on abnormal coagulation function. This cannot be used as an argument when new modern HES preparations with low molecular weight (70,000 or 200,000 dalton) and low degree of substitution (0.5) are used.